Skip to main content
Premium Trial:

Request an Annual Quote

David Ferrick

Premium

David Ferrick has been named vice president of biology and clinical applications at Guava Technologies, the company said on July 6.

Ferrick was previously CEO and director of Sarges Discovery, a Davis, Calif.-based oncogenome research and cancer drug discovery company that Ferrick co-founded in 1999, Guava said. Prior to this, he served as director of molecular and cellular biology at Rigel Pharmaceuticals.

Ferrick also has held numerous academic positions, including associate professor in the department of pathology, microbiology, and immunology at the University of California, Davis. He has also worked at the Ontario Cancer Research Center and the Walter Reed Army Institute. He holds a PhD in immunology from Georgetown University.

 

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.